Naruhiko Ikoma
Univ. Texas MD Anderson Cancer Center
Appearances
- DateMay 9, 2023Long-term survival in patients with localized pancreatic adenocarcinoma (PDAC) or ampullary adenocarcinoma (AA) who undergo resection is rare, even in lymph node (LN)-negative disease…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterUniv. Texas MD Anderson Cancer CenterBrody School of Medicine at ECU - DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterUniv. Texas MD Anderson Cancer CenterBrody School of Medicine at ECU - DateMay 9, 2023To achieve adequate surgical exposure of the third portion of the duodenum, the Cattell-Braasch maneuver or right colon mobilization is generally required…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterUniv. Texas MD Anderson Cancer Center - DateMay 6, 2023Laparoscopic fundoplication in patients with a history of lung transplant has an average length of stay (LOS) of 3 days with a 30-day readmission rate of 25%, which is significantly worse compared to the non-lung transplant population…
Presenter
Speakers
- DateMay 7, 2023SOCIETY: SSAT
Moderators
Case Werstern Reserve University - MetroHealth SystemUniv. Texas MD Anderson Cancer CenterUniversity of Wisconsin-Madison - DateMay 7, 2023BACKGROUND: Despite the advances in the multidisciplinary treatment of gastric adenocarcinoma, the overall 5-year survival remains only 33.3% in North America. R0 resection with adequate lymphadenectomy remains the mainstay therapy…
Presenter
Speakers
- DateMay 6, 2023LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterUniv. Texas MD Anderson Cancer CenterBrody School of Medicine at ECU - DateMay 19, 2024BACKGROUND: Risk-stratified pancreatectomy clinical pathways (RSPCP) are associated with reduced length of stay (LOS) and major complications…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterUniv. Texas MD Anderson Cancer CenterBrody School of Medicine at ECUThe University of Texas MD Anderson Cancer Center - DateMay 21, 2024
Presenter
Univ. Texas MD Anderson Cancer Center